The liver diseases treatment market is projected to reach US$ US$ 4,883.5 million by 2025 from US$ 3,426.8 million in 2017; it is expected to register a CAGR of 4.6% from 2018 to 2025.
Liver is an organ that is situated just below the rib cage and on the right side of the abdomen. As essential function of liver is to carry out digestion of food and ridding off the body from toxic substances. A liver disease can either be inherited or may occur due to various factors such as, viruses or excessive consumption of alcohol. Over the time, damage to the liver results in scarring, a condition known as liver cirrhosis. The condition of liver can be diagnosed by methods such as, blood tests, tissue analysis and imaging tests. The imaging modalities covered in the report include, magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound.
The report offers insights and in-depth analysis of the liver diseases treatment market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes the impact of the COVID-19 pandemic on the market across all the regions. The COVID-19 pandemic has disrupted the socioeconomic conditions of various countries across the world. In the North American region, the US was profoundly affected by the outbreak of the COVID-19 pandemic. COVID-19 has been linked to liver illness in an increasing number of patients. Multiple mechanisms can contribute to COVID19 liver injury, including virus-induced systemic inflammation, hypoxia, hepatic congestion, and drug-induced liver disease. COVID-19 has been associated to hepatic decompensation and liver-related mortality in patients with liver cirrhosis. COVID-19's influence on healthcare resources has had a negative impact on chronic liver disease patient treatment and results. As a result, the treatment, diagnosis, and follow-up of individuals with liver disease has decreased, resulting in negative effects for the healthcare industry over the anticipated period. The market, based on region, is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
Lucrative Regions for Liver Treatment Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Prevalence of Cardiovascular Diseases (CVDs)
The geriatric population has been increasing rapidly as compared to the young population. As per data published by the United Nations, in 2017, there were an estimated 962 million people aged 60 or over in the world, which comprised of 13 per cent of the global population. The geriatric population is estimated to grow at a rate of 3 per cent per year. At present, Europe has the highest population aged 60 years and above. The ageing population in the world is projected to reach around 1.4 billion in 2030 and 2.1 billion in 2050 and is expected to reach up to 3.1 billion in 2100. Ageing has been linked with the severity and poor diagnosis of various liver diseases such as, alcoholic liver disease, nonalcoholic fatty liver disease, hepatitis C, and liver transplantation. Various structural as well as microscopic changes are seen in a liver while they are ageing. Its ability to metabolize many substances decreases gradually. Hence, the complications of liver disease also are more severe in the elderly. A study reported, an annual mortality rate of 50% among patients older than 60 years, compared to 7% in patients younger than 60. A report by the Centers for Disease Control and Prevention reported the death rates for chronic liver disease and cirrhosis rose 31% among those age 45 to 64 between 2000 and 2015.
Disease-Based Insights
Based on disease, the liver diseases treatment market is segmented into hepatitis, cirrhosis and cancer. In 2017, cancer held the largest market share. There has been a significant increase in the number of liver cancer cases due to hepatitis infections, smoking, over consumption of alcohol, and obesity. The segment is anticipated to grow with a CAGR of 5.2% during the forecast period.
Liver Diseases treatment Market, by Disease – 2017 and 2025
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Imaging Modality-Based Insights
Based on imaging modality, the liver treatment market is segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Other Imaging Modalities. Computed tomography (CT) segment is anticipated to grow at a CAGR of 4.7% during the forecast period. A CT scan provides accurate information about the size, shape and position of any tumors in the liver or elsewhere in the abdomen, as well as nearby blood vessels. Hence, it is used to identify the location of a tumor, analyze the extent of cancer in the body and also determine whether the disease is responding to treatments.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Liver Diseases Treatment Market: Strategic Insights
Market Size Value in US$ 3,426.8 Million in 2017 Market Size Value by US$ 4,883.5 Million by 2025 Growth rate CAGR of 4.6% from 2018-2025 Forecast Period 2018-2025 Base Year 2018
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Liver Diseases Treatment Market: Strategic Insights
| Market Size Value in | US$ 3,426.8 Million in 2017 |
| Market Size Value by | US$ 4,883.5 Million by 2025 |
| Growth rate | CAGR of 4.6% from 2018-2025 |
| Forecast Period | 2018-2025 |
| Base Year | 2018 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The liver treatment market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide as well as to meet the growing demand.
By Diseases
- Cirrhosis
- Hepatitis
- Cancer
- Others
By Imaging Modality
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Others
By
Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- General Electric
- Koninklijke Philips N.V.
- Siemens AG
- CANON MEDICAL SYSTEMS CORPORATION
- Hitachi, Ltd
- Elekta AB (pub)
- Neusoft Corporation
- Samsung Healthcare
- BPL Medical Technologies
- Cura Healthcare
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Diseases and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. INTRODUCTION 14
1.1 SCOPE OF THE STUDY 14
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 14
2. GLOBAL LIVER TREATMENT MARKET – KEY TAKEAWAYS 15
3. GLOBAL LIVER TREATMENT MARKET – MARKET LANDSCAPE 17
3.1 OVERVIEW 17
3.2 MARKET SEGMENTATION 17
3.2.1 Global Liver Treatment Market – By Disease 18
3.2.2 Global Liver Treatment Market – By Imaging Modality 18
3.2.3 Global Liver Treatment Market – By Geography 19
4. GLOBAL LIVER TREATMENT MARKET – KEY MARKET DYNAMICS 20
4.1 KEY MARKET DRIVERS 20
4.1.1 Increasing Prevalence of Liver Diseases 20
4.1.2 Increasing Geriatric Population 20
4.1.3 Technological Advancements in Imaging Techniques 21
4.2 KEY MARKET RESTRAINTS 21
4.2.1 Stringent Regulatory Validation Requirement 21
4.2.2 High Cost of Imaging Techniques 21
4.3 KEY MARKET OPPORTUNITIES 22
4.3.1 Partnerships and Collaborations Between Market Players 22
4.3.2 Increasing Healthcare Expenditures in Emerging Markets 22
4.4 FUTURE TRENDS 23
4.4.1 Increasing Use of Hybrid Systems for Imaging 23
4.5 IMPACT ANALYSIS 24
5. LIVER TREATMENT MARKET –GLOBAL ANALYSIS 25
5.1 LIVER TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS 25
5.2 GLOBAL LIVER TREATMENT MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 25
5.3 EXPERT OPINIONS 26
6. GLOBAL LIVER TREATMENT MARKET ANALYSIS – BY DISEASES 27
6.1 OVERVIEW 27
6.2 GLOBAL LIVER TREATMENT MARKET SHARE, BY DISEASE 2017 & 2025 (%) 27
6.3 CANCER MARKET 28
6.3.1 Overview 28
6.3.2 Global Cancer Market Revenue and Forecasts to 2025 (US$ Mn) 28
6.4 HEPATITIS MARKET 29
6.4.1 Overview 29
6.4.2 Global Hepatitis Market Revenue and Forecasts to 2025 (US$ Mn) 30
6.5 CIRRHOSIS MARKET 31
6.5.1 Overview 31
6.5.2 Global Cirrhosis Market Revenue and Forecasts to 2025 (US$ Mn) 31
6.6 OTHER DISEASES MARKET 32
6.6.1 Overview 32
6.6.2 Global Other Diseases Market Revenue and Forecasts to 2025 (US$ Mn) 32
7. GLOBAL LIVER TREATMENT MARKET ANALYSIS – BY IMAGING MODALITY 33
7.1 OVERVIEW 33
7.2 GLOBAL LIVER TREATMENT MARKET SHARE, BY IMAGING MODALITY 2017 & 2025 (%) 33
7.3 COMPUTED TOMOGRAPHY (CT) MARKET 34
7.3.1 Overview 34
7.3.2 Global Computed Tomography (CT) Market Revenue and Forecasts to 2025 (US$ Mn) 34
7.4 MAGNETIC RESONANCE IMAGING (MRI) MARKET 35
7.4.1 Overview 35
7.4.2 Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts to 2025 (US$ Mn) 35
7.6 ULTRASOUND MARKET 36
7.6.1 Overview 36
7.6.2 Global Ultrasound Market Revenue and Forecasts to 2025 (US$ Mn) 36
7.7 OTHER IMAGING MODALITIES MARKET 37
7.7.1 Overview 37
7.7.2 Global Other Imaging Modalities Market Revenue and Forecasts to 2025 (US$ Mn) 37
8. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 38
8.1 OVERVIEW 38
8.2 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 39
8.3 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 39
8.4 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 40
8.5 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 40
8.6 US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 41
8.6.1 US Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 42
8.6.2 US Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 42
8.6.3 US Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 43
8.7 CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
8.7.1 Canada Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 44
8.7.2 Canada Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 45
8.7.3 Canada Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 45
8.8 MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
8.8.1 Mexico Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 46
8.8.2 Mexico Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 47
8.8.3 Mexico Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 47
9. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 48
9.1 OVERVIEW 48
9.2 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
9.3 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 49
9.4 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 50
9.5 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 50
9.6 GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
9.6.1 Germany Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 51
9.6.2 Germany Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 52
9.6.3 Germany Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 52
9.7 FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
9.7.1 France Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 53
9.7.2 France Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 54
9.7.3 France Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 54
9.8 UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
9.8.1 UK Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 55
9.8.2 UK Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 56
9.8.3 UK Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 56
10. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 57
10.1 OVERVIEW 57
10.2 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
10.3 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 58
10.4 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 59
10.5 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 59
10.6 JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
10.6.1 Japan Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 60
10.6.2 Japan Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 61
10.6.3 Japan Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 61
10.7 CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
10.7.1 China Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 62
10.7.2 China Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 63
10.7.3 China Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 63
10.8 INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
10.8.1 India Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 64
10.8.2 India Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 65
10.8.3 India Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 65
11. MIDDLE EAST AND AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 66
11.1 OVERVIEW 66
11.2 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
11.3 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 67
11.4 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 68
11.5 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 68
11.6 UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 69
11.6.1 UAE Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 69
11.6.2 UAE Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 70
11.6.3 UAE Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 70
11.7 SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
11.7.1 Saudi Arabia Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 71
11.7.2 Saudi Arabia Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 72
11.7.3 Saudi Arabia Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 72
11.8 SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
11.8.1 South Africa Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 73
11.8.2 South Africa Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 74
11.8.3 South Africa Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 74
12. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 75
12.1 OVERVIEW 75
12.2 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
12.3 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 76
12.4 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 77
12.5 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 77
12.6 BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
12.6.1 Brazil Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 78
12.6.2 Brazil Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 79
12.6.3 Brazil Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 79
13. LIVER TREATMENT MARKET –KEY COMPANY PROFILES 80
13.1 GENERAL ELECTRIC 80
13.1.1 Key Facts 80
13.1.2 Business Description 80
13.1.3 Financial Overview 81
13.1.4 Product Portfolio 81
13.1.5 SWOT Analysis 82
13.1.6 Key Developments 82
13.2 KONINKLIJKE PHILIPS N.V. 83
13.2.1 Key Facts 83
13.2.2 Business Description 83
13.2.3 Financial Overview 84
13.2.4 Product Portfolio 84
13.2.5 SWOT Analysis 85
13.2.6 Key Developments 85
13.3 SIEMENS AG 86
13.3.1 Key Facts 86
13.3.2 Business Description 86
13.3.3 Financial Overview 87
13.3.4 Product Portfolio 87
13.3.5 SWOT Analysis 88
13.3.6 Key Developments 88
13.4 CANON MEDICAL SYSTEMS CORPORATION 89
13.4.1 Key Facts 89
13.4.2 Business Description 89
13.4.3 Financial Overview 90
13.4.4 Product Portfolio 90
13.4.5 SWOT Analysis 91
13.4.6 Key Developments 91
13.5 HITACHI, LTD 92
13.5.1 Key Facts 92
13.5.2 Business Description 92
13.5.3 Financial Overview 92
13.5.4 Product Portfolio 93
13.5.5 SWOT Analysis 93
13.5.6 Key Developments 94
13.6 ELEKTA AB (PUB) 95
13.6.1 Key Facts 95
13.6.2 Business Description 95
13.6.3 Financial Overview 96
13.6.4 Product Portfolio 96
13.6.5 SWOT Analysis 97
13.6.6 Key Developments 97
13.7 NEUSOFT CORPORATION 98
13.7.1 Key Facts 98
13.7.2 Business Description 98
13.7.3 Financial Overview 99
13.7.4 Product Portfolio 99
13.7.5 SWOT Analysis 100
13.7.6 Key Developments 100
13.8 SAMSUNG HEALTHCARE 101
13.8.1 Key Facts 101
13.8.2 Business Description 101
13.8.3 Financial Overview 102
13.8.4 Product Portfolio 102
13.8.5 SWOT Analysis 102
13.8.6 Key Developments 102
13.9 BPL MEDICAL TECHNOLOGIES 103
13.9.1 Key Facts 103
13.9.2 Business Description 103
13.9.3 Financial Overview 103
13.9.4 Product Portfolio 103
13.9.5 SWOT Analysis 104
13.9.6 Key Developments 104
13.10 CURA HEALTHCARE 105
13.10.1 Key Facts 105
13.10.2 Business Description 105
13.10.3 Financial Overview 105
13.10.4 Product Portfolio 106
13.10.5 SWOT Analysis 106
13.10.6 Key Developments 107
14. APPENDIX 108
14.1 ABOUT THE INSIGHT PARTNERS 108
14.2 GLOSSARY OF TERMS 109
14.3 METHODOLOGY 111
14.3.1 Coverage 112
14.3.2 Secondary Research 113
14.3.3 Primary Research 113
LIST OF TABLES
TABLE 1. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 40
TABLE 2. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 41
TABLE 3. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 43
TABLE 4. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 44
TABLE 5. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 46
TABLE 6. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 46
TABLE 7. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 48
TABLE 8. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 48
TABLE 9. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 50
TABLE 10. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 51
TABLE 11. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 53
TABLE 12. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 53
TABLE 13. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 55
TABLE 14. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 55
TABLE 15. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 57
TABLE 16. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 57
TABLE 17. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 59
TABLE 18. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 60
TABLE 19. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 62
TABLE 20. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 62
TABLE 21. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 64
TABLE 22. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 64
TABLE 23. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 66
TABLE 24. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 66
TABLE 25. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 68
TABLE 26. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 69
TABLE 27. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 71
TABLE 28. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 71
TABLE 29. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 73
TABLE 30. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 73
TABLE 31. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 75
TABLE 32. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 75
TABLE 33. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 77
TABLE 34. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 78
TABLE 35. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 80
TABLE 36. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 80
TABLE 37. GLOSSARY OF TERMS, LIVER TREATMENT MARKET 110
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 16
FIGURE 2. GLOBAL LIVER TREATMENT MARKET BY DISEASE, MARKET SHARE (%), 2017 17
FIGURE 3. GLOBAL LIVER TREATMENT MARKET BY IMAGING MODALITY, MARKET SHARE (%), 2017 17
FIGURE 4. LIVER TREATMENT MARKET SEGMENTATION 18
FIGURE 5. LIVER TREATMENT SEGMENTATION, BY REGION 19
FIGURE 6. LIVER TREATMENT MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 25
FIGURE 7. GLOBAL LIVER TREATMENT MARKET – REVENUE FORECASTS AND ANALYSIS – 2017- 2025 26
FIGURE 8. GLOBAL LIVER TREATMENT MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 27
FIGURE 9. GLOBAL LIVER TREATMENT MARKET SHARE, BY DISEASE, 2017 & 2025 (%) 28
FIGURE 10. GLOBAL CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 29
FIGURE 11. GLOBAL HEPATITIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 31
FIGURE 12. GLOBAL CIRRHOSIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 32
FIGURE 13. GLOBAL OTHER DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 33
FIGURE 14. GLOBAL LIVER TREATMENT MARKET SHARE, BY IMAGING MODALITY, 2017 & 2025 (%) 34
FIGURE 15. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 35
FIGURE 16. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 36
FIGURE 17. GLOBAL ULTRASOUND MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 37
FIGURE 18. GLOBAL OTHER IMAGING MODALITIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 38
FIGURE 19. NORTH AMERICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 39
FIGURE 20. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 40
FIGURE 21. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 41
FIGURE 22. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 43
FIGURE 23. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 24. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 25. EUROPE LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 49
FIGURE 26. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 27. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 51
FIGURE 28. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 29. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 30. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 31. ASIA PACIFIC LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 58
FIGURE 32. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 33. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 60
FIGURE 34. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 35. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
FIGURE 36. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
FIGURE 37. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 67
FIGURE 38. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 39. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 69
FIGURE 40. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
FIGURE 41. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
FIGURE 42. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
FIGURE 43. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 76
FIGURE 44. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 77
FIGURE 45. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 78
FIGURE 46. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
The List of Companies
1. General Electric
2. Koninklijke Philips N.V.
3. Siemens AG
4. CANON MEDICAL SYSTEMS CORPORATION
5. Hitachi, Ltd
6. Elekta AB (pub)
7. Neusoft Corporation
8. Samsung Healthcare
9. BPL Medical Technologies
10. Cura Healthcare
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Liver Diseases Treatment Market
Sep 2018
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2018
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2018
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)